Avanos Medical Expects 2024 Net Sales of $685M-$705M Vs $690.13M Est, Adj EPS of $1.30-$1.45 Vs $1.38 Est

2024 Outlook

The Company expects 2024 net sales to be between $685 and $705 million, which assumes organic growth between 3% to 6%, excluding the impact of the product portfolio rationalization under the Transformation Process. Adjusted gross profit margins are expected to be between 59.5% and 60.5%, adjusted SG&A as a percentage of revenue is expected to be between 41% and 42%, and adjusted diluted earnings per share are expected to be between $1.30 to $1.45.